Anticoagulant activity in salivary gland homogenates of Thyrsopelma guianense (Diptera: Simuliidae), the primary vector of onchocerciasis in the Brazilian Amazon

Anticoagulant activity in salivary gland homogenates of Thyrsopelma guianense (Diptera: Simuliidae), the primary vector of onchocerciasis in the Brazilian Amazon

In this study, anticoagulant activity was detected in salivary gland homogenates (SGHs) of Thyrsopelma guianense (Diptera: Simuliidae). The SGH yielded 1.07 μg ± 0.03 (n = 15) of total soluble protein per pair of glands. In addition, following SDS-PAGE (12.5% gel) and silver nitrate stainin...

Full description

Bibliographic Details
Main Authors:	Andrezza Campos Chagas, Jansen Fernandes Medeiros, Spartaco Astolfi-Filho, Victor Py-Daniel
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2010-03-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	black flies salivary glands anticoagulant onchocerciasis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000200011

Similar Items

Onchocerciasis: the beginning of the end?
by: Adrian Hopkins
Published: (2019-02-01)

The Potential for Dispersal of Onchocerciasis in Ecuador in Relation to the Distribution of the Vector Simulium exiguum (Diptera:Simuliidae)
by: Charalambous M, et al.
Published: (1997-01-01)

Description of the female of Thyrsopelma itaunense (Diptera, Simuliidae)
by: Milton Norberto Strieder
Published: (2004-06-01)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
by: Ed Cupp, et al.
Published: (2019-07-01)

Onchocerciasis in the forest-savannah mosaic area of Nigeria
by: C P Chijioke, et al.
Published: (1998-01-01)

Guianensin, a Simulium guianense salivary protein, has broad anti-hemostatic and anti-inflammatory properties
by: Paola Carolina Valenzuela-Leon, et al.
Published: (2023-07-01)

Information for onchocerciasis control
by: Adrian Hopkins
Published: (2010-12-01)

Onchocerciasis in Ecuador: the situation in 1989
by: Ronald H. Guderian, et al.
Published: (1992-09-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
by: Ángel Guevara, et al.
Published: (2018-04-01)

Onchocerciasis then and now: achievements, priorities and challenges
by: Adrian Hopkins
Published: (2018-01-01)

Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach
by: Carabin Hélène, et al.
Published: (2003-01-01)

Anticoagulation activity of salivary gland extract of oriental blackfly Simulium indicum
by: Subhalaxmi Borah, et al.
Published: (2014-05-01)

Onchocerciasis Elimination: Progress and Challenges
by: Lakwo T, et al.
Published: (2020-10-01)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
by: Alfred Dusabimana, et al.
Published: (2022-02-01)

Ivermectin therapy for onchocerciasis: Effect on some haematological and biochemical parameters
by: E N Shu, et al.
Published: (2008-01-01)

Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa
by: Gebremedhin Gebrezgabiher, et al.
Published: (2019-07-01)

Identification of vector species (Diptera: Simuliidae) of human onchocerciasis in the Amazonia focus of Brazil and Venezuela Identificação das espécies vetoras (Diptera: Simuliidae) de oncocercose humana no foco da Amazônia do Brasil e da Venezuela
by: A. J. Shelley, et al.
Published: (1987-12-01)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2019-05-01)

Onchocerciasis in Ecuador: Prevalence of Infection on the Ecuador-Colombia Border in the Province of Esmeraldas
by: Joy R Guderian, et al.
Published: (1997-03-01)

River-specific macrogenomic diversity in Simulium guianense s. l. (Diptera: Simuliidae), a complex of tropical American vectors associated with human onchocerciasis.
by: Peter H Adler, et al.
Published: (2017-01-01)

Human onchocerciasis in Brazil: an overview
by: Shelley Anthony J.
Published: (2002-01-01)

Human onchocerciasis in Brazil: an overview
by: Anthony J. Shelley

Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?
by: Cabirou Mounchili Shintouo, et al.
Published: (2021-08-01)

Status of Onchocerciasis Elimination in Gabon and Challenges: A Systematic Review
by: Elsa-Rush Eyang-Assengone, et al.
Published: (2023-07-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

Investigation of publication trends and hot topics on onchocerciasis between 2000 and 2022
by: Sevil Alkan, et al.
Published: (2023-09-01)

The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
by: Chris A. Schmidt, et al.
Published: (2022-09-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01)

Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria
by: S.O. Sam-Wobo , M.A. Adeleke , O.A. Jayeola , A.O. Adeyi , A.S. Oluwole , M. Ikenga , A. Lawniye , J. Gazama , A. Kagni , T.O. Kosoko , O. Agbeyangi , S. Bankole , L. Toé , C.F. Mafiana & L. Yameogo
Published: (2012-06-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
by: Adugna Endale, et al.
Published: (2015-02-01)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected
by: Honorat GM Zouré, et al.
Published: (2014-07-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
by: Robert Colebunders, et al.
Published: (2022-03-01)

Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East
by: Ahmad Mansour, et al.
Published: (2023-12-01)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018-08-01)

Historical Review and Cost-Effectiveness Assessment of the Programs to Eliminate Onchocerciasis and Trachoma in Mexico
by: Fernández-Santos NA, et al.
Published: (2021-10-01)

Research for new drugs for elimination of onchocerciasis in Africa
by: Annette C. Kuesel
Published: (2016-12-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
by: Robert Colebunders, et al.
Published: (2024-01-01)